GreenHouse Holdings, Inc., a leading provider of energy efficiency solutions and sustainable infrastructure products, encourages and assists companies of all sizes with efforts to identify and adopt strategies that fully incorporate the various incentive programs offered through their local utilities. These programs provide significant monetary incentives for acting on projects that improve energy efficiency and pays consumers for participating in periodic consumption reductions (Demand Response or DR) -- increasing a business' bottom line for the coming year.
Automated Demand Response (ADR) is one of several DR programs available to commercial and industrial customers of California's three Investor Owned Electric Utilities. The ADR programs as delivered by GRHU provides participating utility customers with the investigative, engineering and installation solutions (hardware and software) required to conduct a fully-automated (hands-free) load-shed. GreenHouse is uniquely organized with a professional and technical staff capable of delivering end-to-end ADR solutions.
The question most frequently asked of GRHU by its clients is how to reduce (utility-influenced) operational costs by managing consumption. In an effort to be more sustainable or green, GRHU suggests companies adapt the following strategies and tactics to their business plan for 2011:
- When starting a consumption-related utility incentive program, partner with only highly reputable companies who know all of the facts; bad choices can actually escalate costs
- Use the latest in lighting technology and embrace proper lighting techniques for businesses
- Automation -- the backbone of the energy efficiency process worldwide. Install an Automated Demand Response program (ADR) for energy efficiency and load curtailment
- Renewable Fuels (wind, solar, etc.) -- Part of the equation, not the solution
To learn more about GRHU visit: http://www.greenhouseintl.com
Impax Laboratories Inc. (Nasdaq:IPXL) announced that the Company will present at the J.P. Morgan 29th Annual Healthcare Conference on Monday, January 10, at 4:00 p.m. PT. The conference will be held at the Westin St. Francis, San Francisco, CA. Individuals may listen to the live or an archived presentation made at the conference, which will be posted in the investor relations section of the Company’s web site at www.impaxlabs.com. This presentation will be archived on the Company’s web site for 30 days.
Impax Laboratories, Inc., a specialty pharmaceutical company, engages in the development and commercialization of bioequivalent and brand-name pharmaceuticals. It operates in two divisions, Global Pharmaceuticals and Impax Pharmaceutical. The Global Pharmaceuticals division develops, manufactures, sells, and distributes generic pharmaceutical products.
Marvell Technology Group Ltd. (Nasdaq:MRVL) announced the Marvell mPrint, a printing platform that demonstrates how Marvell's technologies can be integrated into a single platform, enabling wireless printing, scanning and document management for business users and consumers – a need that is becoming increasingly important in mobile world. As a leading supplier to the printing industry, we're very proud to bring new, cutting-edge capabilities for the global population of end users who want to be able to seamlessly print high-quality photos, documents or images from all of their devices anywhere and at any time," said Weili Dai, Co-founder of Marvell. "Marvell mPrint platform makes printing and scanning much more dynamic. I believe this truly meets the needs of a global population for whom life is mobile.
Marvell Technology Group Ltd. designs, develops, and markets analog, mixed-signal, and digital signal processing and embedded microprocessor integrated circuits. The company offers storage products, including storage system-on-a-chip, read channel, hard disk controller, tape drive controllers, solid-state drive controllers, and storage-system products for hard disk drives, tape drive electronics, optical disk drives, solid-state flash drives.
American Video Teleconferencing Corp. (OTCPK:AVOT)
China has been one of the main supplier to the US of the Earth's rare mineral supplies, with these rare minerals American manufacturers are able to make high-tech products such as cell phones, wind turbines, and guided missiles, but all that might come to a screeching halt now that China has stopped supplying the material, the New York Times has reported.
In the wake of China's decision America now must look for other sources, that will be more reliable for our future needs, and AVOT may just be the new source, here's why.
AVOT believes the rare earths industry is where it wants to maintain a very strong focus and is looking to expand its holdings. AVOT is currently looking for these Rare Earths Minerals in Canada, the US's Northern neighbor.
AVOT is pleased to announce that it has hired a French speaking geologist to search the archives of the Quebec Department of Mines for Rare Earths showings not on a current computer file. AVOT believes the rare earths industry is where it wants to maintain a very strong focus and is looking to expand its holdings. As neither the Federal nor Quebec Governments have carried out any air borne surveys in this area, AVOT will seek a contractor to do an air borne Mag-EM radiometric survey. This survey will cover its present holdings and the immediate surrounding area looking for future acquisitions. We are pleased to be working in the Province of Quebec as it is rated the number one jurisdiction in the world to carry out mineral exploration. The Quebec Government gives a rebate up to 45% for property expenditures.
ViroPharma Inc. (Nasdaq:VPHM) announced that Vincent Milano, president and chief executive officer of ViroPharma, will present at the 29th Annual J.P. Morgan Healthcare Conference at 6:00 P.M. ET (3:00 P.M. PT) on Wednesday, January 12, 2011. The conference is being held at the Westin St. Francis Hotel in San Francisco. ViroPharma's presentations will be webcast live for investors through www.viropharma.com and available for a period of 14 days.
ViroPharma Incorporated, a biopharmaceutical company, engages in the development and commercialization of products that address serious diseases with a focus on products used by physician specialists or in hospital settings in the United States and internationally.
Signup for FREE Daily Stock Alerts From CRWEFinance.com/signup
THIS IS NOT A RECOMMENDATION TO BUY OR SELL ANY SECURITY!
Disclaimer: Never invest in any stock featured on our site or emails unless you can afford to lose your entire investment. CRWEFinance.com publisher and its affiliates and contractors are not registered investment advisers or broker/dealers. Our disclaimer is to be read and fully understood before using our site, reading our newsletter or joining our email list. Release of Liability: Through use of this website viewing or using, you agree to hold CRWEFinance.com report and Crown Equity Holdings Inc. CRWE, its operators, shareholders, employees and/or contractors harmless and to completely release them from any and all liability due to any and all loss (monetary or otherwise), damages (monetary or otherwise) that you may occur. (Read more at http://crwefinance.com/disclaimer) Rule 17B requires disclosure of payment for investor relations. Crown Equity Holdings Inc. (OTCPK:CRWE) is a newswire as well as an IR and PR firm. Crown Equity Holdings Inc. (OTCPK:CRWE), in some cases, provides media advertising and public awareness for both public and private companies, as well as disseminating news. As such, in some cases, when Crown Equity Holdings Inc. (OTCPK:CRWE) advertises for a particular client, Crown Equity Holdings Inc. (OTCPK:CRWE) charges an advertising fee which it must disclose under 17B. The fee may be in cash, in free trading stock or in restricted stock.Crown Equity Holdings Inc. (OTCPK:CRWE) has received ten thousand dollars in cash and anticipates another ten thousand dollars in cash from the company for 60 days of advertisement services for Green House Holdings, Inc. (OTCQB:GRHU). In addition to the cash, Crown Equity Holdings Inc. (OTCPK:CRWE) also anticipates receiving 20,000 shares of 144 restricted stocks from a third party. Crown Equity Holdings Inc. (OTCPK:CRWE) has received from the company 2,000,000 shares of (144) restricted common stock of American Video Teleconferencing Corp. (OTCPK:AVOT) for 12 months IR Services and 1,000,000 shares of (144) restricted common stock for its IT services.